- Home
- BCAB vs JFU Comparison
BCAB vs JFU Comparison
Compare BCAB & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCAB | JFU |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 58.2M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BCAB | JFU |
|---|---|---|
| Price | $0.77 | $6.08 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 7.6K |
| Earning Date | 11-13-2025 | 12-09-2022 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3110.57 |
| EPS | N/A | ★ 3.04 |
| Revenue | N/A | ★ $44,573,690.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.73 |
| Revenue Growth | N/A | ★ 8.19 |
| 52 Week Low | $0.24 | $1.01 |
| 52 Week High | $1.65 | $6.84 |
Technical Indicators
Market Signals| Indicator | BCAB | JFU |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 79.78 |
| Support Level | $0.79 | $4.57 |
| Resistance Level | $0.90 | $4.94 |
| Average True Range (ATR) | 0.14 | 0.34 |
| MACD | -0.02 | 0.16 |
| Stochastic Oscillator | 12.90 | 99.26 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.